Yael Hayon

Insider Reports History

Location
Carmiel, Israel
Signature
/s/ Eyal Rubin, POA
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yael Hayon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. VP, Research & Development Common Stock 35,115 $49,512 $1.41 15 Aug 2023 By Trust
Protalix BioTherapeutics, Inc. VP, Research & Development Stock Options (Right to Buy) 35,115 15 Aug 2023 Direct

Insider Reports Filed by Yael Hayon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLX Protalix BioTherapeutics, Inc. 15 Aug 2023 2 $0 4 VP, Research & Development 17 Aug 2023, 16:30
PLX Protalix BioTherapeutics, Inc. 07 Sep 2022 1 $0 4 VP, Research & Development 09 Sep 2022, 17:03